About ONO PHARMACEUTICAL
ONO PHARMACEUTICAL is a publicly listed company based in Osaka (Japan) founded in 1947. RD company focused on manufacturing of drugs for multiple therapeutic areas. ONO PHARMACEUTICAL has completed 1 acquisition, including Deciphera. Its website ono-pharma.com draws about 112 thousand monthly visits. Its focus areas include Diversified Pharmaceuticals and Drugs.
Company details
ONO Pharmaceutical was established in 1947 in Osaka, Japan, as a research and development entity within the pharmaceutical sector. Operations center on the production of medications targeting various therapeutic areas, including immunology and oncology. Services encompass drug discovery, clinical trials, and global distribution, with headquarters maintained in Japan and international partnerships facilitated.
- Headquarters Osaka, Japan
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website ono-pharma.com/ja
- Social YouTube
- Legal Name Ono Pharmaceutical Co., Ltd.
- Annual Revenue$3.23 B (USD)5.94as on Mar 31, 2026
- Net Profit$437.44 M (USD)39.4as on Mar 31, 2026
- EBITDA$884.59 M (USD)56.28as on Mar 31, 2026
- Investments & Acquisitions
Apps and channels of ONO PHARMACEUTICAL
its YouTube channel 小野薬品 ONO PHARMACEUTICAL official has 489 subscribers and 19 videos.
Videos from ONO PHARMACEUTICAL
The most watched videos on ONO PHARMACEUTICAL's YouTube channel, 小野薬品 ONO PHARMACEUTICAL official (489 subscribers). Click a video to play it here.
More on 小野薬品 ONO PHARMACEUTICAL official .
People of ONO PHARMACEUTICAL
18 people are tracked at ONO PHARMACEUTICAL (14 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Kunihiro Nakano | Senior Director, Asian Business Department | Leadership |
Yasunori Ninomiya | Head Of Global Marketing | Leadership |
Gyo Sagara | President and CEO | Leadership |
U. Shivraj Sohur | Vice President | Neurology Clinical Development | Leadership |
Masao Akamatsu | Associate Director, Business Development, Corporate Development & Strategy | Leadership |
Shigetaka Komeda | Head, Sales Field Digital Enablement, Sales Management | Leadership |
Takaaki Nakamura | Director, Primary Clinical Development Planning III (immunology & Speciality Area) | Leadership |
Tomoya Ohno | Senior Director Of Primary Clinical Development | Leadership |
Koichiro Terai | Head Of Business Development Japan HQ | Leadership |
Junsaku Kitagawa | Associate Director Of Clinical Pharmacology | Leadership |
Akifumi Fujii | Project Lead/director | Leadership |
Yukinori Nakata | Associate Director Of Global Market Access | Leadership |
Kunihiko Ito | Corporate Officer / Head Of Global Business | Leadership |
Kasumi Komiya | Senior Director Of Operations | Leadership |
Tomohiro H. | Corporate Communications | Team |
Mototsugu Tsutsui | Senior Manager | Team |
Masakazu Konno | Senior Manager | Team |
Junichi Yoshioka | Business Development Manager | Team |
Complete people profiles for ONO PHARMACEUTICAL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ONO PHARMACEUTICAL
ONO PHARMACEUTICAL is a publicly listed company on the TSE with ticker symbol 4528 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 Jun 1963
- Listed onTSE: 45280
- Listed entityONO Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3197600004
- Share price2,265.50 JPY (-1.37% on the day) · 2026-10-14
- Market capitalisation1,078,780,217,773.00 JPY
- Price to earnings14.0
- EPS (diluted, trailing year)162.22 JPY
- Dividend yield3.54%
- Volume (last session)1,531,600
Financials of ONO PHARMACEUTICAL
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 515.78B JPY | 69.77B JPY | 141.09B JPY |
| 2024 | 486.87B JPY | 50.05B JPY | 90.28B JPY |
| 2023 | 502.67B JPY | 127.98B JPY | 181.70B JPY |
| 2022 | 447.19B JPY | 112.72B JPY | 169.75B JPY |
| 2021 | 361.36B JPY | 80.52B JPY | 132.63B JPY |
Detailed financial statements for ONO PHARMACEUTICAL
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ONO PHARMACEUTICAL
ONO PHARMACEUTICAL has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Deciphera.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Type 2 kinase inhibitors for cancer treatment are developed. | deciphera.com | Waltham, United States | 2003 | Apr 2024 | $2.4B |
Complete acquisition details for ONO PHARMACEUTICAL
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ONO PHARMACEUTICAL
3 dated milestones of ONO PHARMACEUTICAL across 77 years, from founding to its latest funding, stage changes and deals.
- Founded ONO PHARMACEUTICAL is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Deciphera.
Web traffic of ONO PHARMACEUTICAL
The website of ONO PHARMACEUTICAL (ono-pharma.com) receives about 112.3K visits a month and ranks #536,517 among all websites worldwide, #557 in Biotechnology and Pharmaceuticals.
- Monthly visits112.3K
▲ 107.4% vs previous month
- Unique visitors23.8K
per month
- Global rank#536,517
among all websites
- Category rank#557
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit3.2
- Average visit2 min 07 sec
- DevicesDesktop 58% Β· Mobile 42%
Websites whose visitors overlap most with ONO PHARMACEUTICAL. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mixonline.jp | 100% | #252,634 | View details | ||
opdivo.jp | opdivo.jp | 93% | #3,078,803 | β | |
| chordiatherapeutics.com | 88% | 5.3K | #3,081,691 | View details | |
onopharma365.sharepoint.com | onopharma365.sharepoint.com | 85% | β | ||
iyakutsushinsha.com | iyakutsushinsha.com | 85% | #1,697,967 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for ONO PHARMACEUTICAL
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ono Pharmaceutical
Complete news archive for ONO PHARMACEUTICAL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ONO PHARMACEUTICAL
ONO PHARMACEUTICAL was founded in 1947.
ONO PHARMACEUTICAL is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Annual revenue of ONO PHARMACEUTICAL is $3.23B as on Mar 31, 2026.
ONO Pharmaceutical was established in 1947 in Osaka, Japan, as a research and development entity within the pharmaceutical sector. Operations center on the production of medications targeting various therapeutic areas, including immunology and oncology. Services encompass drug discovery, clinical trials, and global distribution, with headquarters maintained in Japan and international partnerships facilitated.
Yes, ONO PHARMACEUTICAL is publicly traded on TSE under the ticker symbol 4528.
ONO PHARMACEUTICAL has made 1 acquisition, including Deciphera.
The website of ONO PHARMACEUTICAL receives about 112 thousand visits a month and ranks #536,517 among all websites worldwide.